NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform's comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans and CMS for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks. In addition, it offers Quadris, a data solution that includes multi-data analysis, reporting, and professional services. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was incorporated in 2010 and is headquartered in Morrisville, North Carolina. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.

NantHealth, Inc.

Healthcare Pharmaceuticals is involved in the pharmaceuticals sector, providing healthcare-related products and services.

Healthcare Pharmaceuticals

iPLATO provides solutions that transform primary care and population health through patient engagement.

iPLATO

NantHealth builds technology that simplifies healthcare. The company facilitates collaboration between payers and providers to improve patient care efficiency.

Metric
Company Name	NantHealth, Inc.	Healthcare Pharmaceuticals	iPLATO
Symbol	NH
MSH ID	COM:NANTHEALTH	COM:HPLBD	COM:IPLATO
Market	STOCKS	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Healthcare & Health Services
Industry	Medical - Healthcare Information Services	Pharmaceuticals	Health Technology
Country	US	BD	GB
Stage
Employee Count	365
Website	nanthealth.com	hplbd.com	iplato.com
LinkedIn
Founders

Metric
Market Cap	10.40M
Enterprise Value
Monthly Web Traffic		20.34K	2.47K
Web Traffic Growth		0.50	-0.60
Valuation
Raised Capital			2.08M

Metric
Revenue	67.00M
Revenue (LTM)
Revenue (NTM)
Gross Profit	38.16M
EBITDA	-37.98M
Operating Income	-51.33M
Net Income	-67.78M
EPS	-8.80
Diluted EPS	-8.80
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.61
Operating Profit Margin	-0.69
EBITDA Margin	-0.57
Net Profit Margin	-1.09
Return on Equity	0.29
Return on Assets	-0.48
Return on Capital Employed	1.00

COM:NANTHEALTH

NantHealth

Last Close

1.35

14/11 21:00

Market Cap

10.40M

Beta: -

Volume Today

197.97K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-0.16
P/B Ratio	-0.04
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	0.16
EV Multiple	1.93

Metric
Days Sales Outstanding	38.87
Days Payables Outstanding	126.87
Days Inventory Outstanding
Operating Cycle	25.99
Cash Conversion Cycle	-71.70
Asset Turnover	0.44

Metric
Operating Cash Flow	-32.26M
Free Cash Flow	-38.73M
Cash Flow to Debt	-0.14
Operating Cash Flow/Sales	-0.21
Free Cash Flow Yield	-3.30

Metric
Cash & Equivalents	1.76M
Accounts Receivable	-204K
Inventory	2.75M
Goodwill	98.33M
Debt to Capitalization	-0.65
Debt to Assets	1.70
Current Ratio	0.64
Quick Ratio	0.05

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.06
R&D to Revenue	0.33
SG&A to Revenue